Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
12 Week Treatment	STARTED	K-321 QID	21
12 Week Treatment	STARTED	K-321 BID	22
12 Week Treatment	STARTED	Placebo	22
12 Week Treatment	COMPLETED	K-321 QID	21
12 Week Treatment	COMPLETED	K-321 BID	22
12 Week Treatment	COMPLETED	Placebo	20
12 Week Treatment	NOT COMPLETED	K-321 QID	0
12 Week Treatment	NOT COMPLETED	K-321 BID	0
12 Week Treatment	NOT COMPLETED	Placebo	2
40 Week Follow-up Observation	STARTED	K-321 QID	21
40 Week Follow-up Observation	STARTED	K-321 BID	22
40 Week Follow-up Observation	STARTED	Placebo	22
40 Week Follow-up Observation	COMPLETED	K-321 QID	21
40 Week Follow-up Observation	COMPLETED	K-321 BID	21
40 Week Follow-up Observation	COMPLETED	Placebo	20
40 Week Follow-up Observation	NOT COMPLETED	K-321 QID	0
40 Week Follow-up Observation	NOT COMPLETED	K-321 BID	1
40 Week Follow-up Observation	NOT COMPLETED	Placebo	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04250207/flow